BSPM [Biostar Pharmaceuticals,] 10-K: (Original Filing)

[FORM 10-K (Mark One) x December 31, 2011 For the fiscal year ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [List of subsidiary / variable interest entities of Biostar Pharmaceuticals, Inc. as of December 31, 2011 Subsidiary Place of incorporation Shaanxi Biostar BioTech Ltd. People’s Republic of China Variable interest entities Place of incorporation Shaanxi Aoxing Pharmaceutical Co., Ltd, People’s Republic of China Shaanxi Weinan Aoxing Pharmaceuticals, LLC People’s Republic of China EX-21 2 ex21.htm] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to your incorporation of our audit report dated March 27, 2012 relating to the consolidated financial statements of Biostar Pharmaceuticals, Inc. as of and for each of the years ended December 31, 2011 and 2010 in the Annual Report on Form] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. (No. 333-161598) We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 Mazars CPA Limited Certified Public Accountants Hong Kong March 27, 2012 EX-23.2 4 ex23-2.htm] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION I, Zack Zibing Pan, certify that: 1. I have reviewed this annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 7 ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 8 ex32-2.htm]

By | 2016-03-03T12:11:13+00:00 March 27th, 2012|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 10-K: FORM 10-K (Mark One) x December 31, 2011

[FORM 10-K (Mark One) x December 31, 2011 For the fiscal year ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [List of subsidiary / variable interest entities of Biostar Pharmaceuticals, Inc. as of December 31, 2011 Subsidiary Place of incorporation Shaanxi Biostar BioTech Ltd. People’s Republic of China Variable interest entities Place of incorporation Shaanxi Aoxing Pharmaceutical Co., Ltd, People’s Republic of China Shaanxi Weinan Aoxing Pharmaceuticals, LLC People’s Republic of China EX-21 2 ex21.htm] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to your incorporation of our audit report dated March 27, 2012 relating to the consolidated financial statements of Biostar Pharmaceuticals, Inc. as of and for each of the years ended December 31, 2011 and 2010 in the Annual Report on Form] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. (No. 333-161598) We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 Mazars CPA Limited Certified Public Accountants Hong Kong March 27, 2012 EX-23.2 4 ex23-2.htm] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION I, Zack Zibing Pan, certify that: 1. I have reviewed this annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 7 ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 8 ex32-2.htm]

By | 2016-03-03T12:12:52+00:00 March 27th, 2012|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 10-K: FORM 10-K (Mark One) x December 31, 2011

[FORM 10-K (Mark One) x December 31, 2011 For the fiscal year ended: Or For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, Maryland 20-8747899 (State or other jurisdiction oforporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China] [List of subsidiary / variable interest entities of Biostar Pharmaceuticals, of December 31, 2011 Subsidiary Place oforporation Shaanxi Biostar BioTech Peoples Republic of China Variable interest entities Place oforporation Shaanxi Aoxing Pharmaceutical Peoples Republic of China Shaanxi Weinan Aoxing Pharmaceuticals, Peoples Republic of China] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, We herebynsent to yourorporation of our audit reportted March 27, 2012 relating to thensolidated financial statements of Biostar Pharmaceuticals, of and for each of the years ended December 31, 2011 and 2010 in the Annual Report on Form 10-K of] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, (No. 333-161598) We herebynsent to theorporation by reference in the Registration Statement on Form S-8 Mazars CPA Limited Certified Public Accountants Hong Kong March 27, 2012 ex23-2.htm 4 EX-23.2] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this annual 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with] [CERTIFICATION I, Zack Zibing Pan, certify that: 1. I have reviewed this annual 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Ronghua Wang Chief Executive Officer ex32-1.htm 7 EX-32.1] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) ex32-2.htm 8 EX-32.2]

By | 2016-02-07T15:55:09+00:00 March 27th, 2012|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

LFC [CHINA LIFE INSURANCE CO] 6-K: CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock

[CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the People’s Republic of China with limited liability) (the “Company”) (Stock Code: 2628) IMPORTANT Announcement on the Resolutions of the Seventeenth Meeting of the Third Session of the Board of Directors of China Life Insurance Company Limited The seventeenth meeting (the “Meeting”) of the third session of the] [CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the People’s Republic of China with limited liability) (the “Company”) (Stock Code: 2628) IMPORTANT Announcement on Resolutions of the Sixteenth Meeting of the Third Session of the Board of Supervisors China Life Insurance Company Limited (the “Company”) The sixteenth meeting (the “Meeting”) of the third session of the] [Description 99.1 99.2]

By | 2016-03-28T06:54:55+00:00 March 27th, 2012|Categories: Chinese Stocks, LFC, Webplus ver|Tags: , , , , , |0 Comments

LFC [CHINA LIFE INSURANCE CO] 6-K: (Original Filing)

[(A joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 2628) ANNOUNCEMENT OF RESULTS FOR THE YEAR ENDED 31 DECEMBER 2011 CHAIRMAN’S STATEMENT During the Reporting Period, the Company’s total revenues reached RMB370,899 million, a decrease of 3.9% from 2010. As at the end of the Reporting Period, the Company’s total assets reached] [Description 99.1 Announcement, dated March 26, 2012]

By | 2016-03-28T06:57:08+00:00 March 27th, 2012|Categories: Chinese Stocks, LFC, SEC Original|Tags: , , , , , |0 Comments

LFC [CHINA LIFE INSURANCE CO] 6-K: (A joint stock limited company incorporated in the

[(A joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 2628) ANNOUNCEMENT OF RESULTS FOR THE YEAR ENDED 31 DECEMBER 2011 CHAIRMAN’S STATEMENT During the Reporting Period, the Company’s total revenues reached RMB370,899 million, a decrease of 3.9% from 2010. As at the end of the Reporting Period, the Company’s total assets reached] [Description 99.1 Announcement, dated March 26, 2012]

By | 2016-03-28T06:58:02+00:00 March 27th, 2012|Categories: Chinese Stocks, LFC, Webplus ver|Tags: , , , , , |0 Comments

KGJI [KINGOLD JEWELRY] 8-K: (Original Filing)

[KINGOLD JEWELRY REPORTS 2011 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS Company to Hold Conference Call with Accompanying Slide Presentation On March 27, 2011, at 8:30 a.m. ET WUHAN CITY, China, March 26, 2012 -- Kingold Jewelry, Inc. (NASDAQ: KGJI) Mr. Zhihong Jia, Chairman and CEO of Kingold, stated, “We were pleased to report solid operating results in 2011. Our focus] []

By | 2016-03-16T17:30:06+00:00 March 27th, 2012|Categories: Chinese Stocks, KGJI, SEC Original|Tags: , , , , , |0 Comments

HNP [HUANENG POWER INTERNATIONAL] 6-K: (Original Filing)

[This Form 6-K consists of: PROVISION OF EXTERNAL GUARANTEE For background information relating to this announcement, please refer to an announcement published by Huaneng Power International, Inc. (the ÒCompanyÓ) published on 2 December 2010 (the ÒAnnouncementÓ). Unless defined otherwise, the terms used in this announcement shall have the same meaning used in the Announcement. When the Company acquired the 50%]

By | 2016-03-30T14:23:01+00:00 March 27th, 2012|Categories: Chinese Stocks, HNP, SEC Original|Tags: , , , , , |0 Comments

KGJI [KINGOLD JEWELRY] 8-K: KINGOLD JEWELRY REPORTS 2011 FOURTH QUARTER AND YEAR-END

[KINGOLD JEWELRY REPORTS 2011 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS Company to Hold Conference Call with Accompanying Slide Presentation On March 27, 2011, at 8:30 a.m. ET WUHAN CITY, China, March 26, 2012 -- Kingold Jewelry, Inc. (NASDAQ: KGJI) Mr. Zhihong Jia, Chairman and CEO of Kingold, stated, “We were pleased to report solid operating results in 2011. Our focus] []

By | 2016-03-16T17:31:25+00:00 March 27th, 2012|Categories: Chinese Stocks, KGJI, Webplus ver|Tags: , , , , , |0 Comments

HNP [HUANENG POWER INTERNATIONAL] 6-K: This Form 6-K consists of: PROVISION OF EXTERNAL

[This Form 6-K consists of: PROVISION OF EXTERNAL GUARANTEE For background information relating to this announcement, please refer to an announcement published by Huaneng Power International, Inc. (the ÒCompanyÓ) published on 2 December 2010 (the ÒAnnouncementÓ). Unless defined otherwise, the terms used in this announcement shall have the same meaning used in the Announcement. When the Company acquired the 50%]

By | 2016-03-30T14:24:11+00:00 March 27th, 2012|Categories: Chinese Stocks, HNP, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar